文献速递颈动脉与弓上血管

高危解剖或生理特征患者颈动脉内膜切除术后当代结局

Contemporary outcomes after carotid endarterectomy in high-risk anatomic and physiologic patients.
PubMed 文献 · J Vasc Surg · 2019-08-20

基于ACS NSQIP血管靶向数据库2011-2017年25788例颈动脉内膜切除术患者的回顾性分析,评估CMS高危生理或解剖标准对术后30天卒中/死亡的影响。高危生理或解剖患者卒中/死亡率均高于正常风险患者,无症状高危生理患者30天卒中/死亡率达4.7%,远超3%阈值。

要点

  • 高危生理或解剖特征与颈动脉内膜切除术后30天卒中/死亡率升高相关。
  • 无症状高危生理患者30天卒中/死亡率为4.7%,超过指南3%阈值。
  • 仅高危解剖患者颅神经损伤率升高,高危生理患者未见差异。

核心结论

  • 按当前标准筛选的无症状颈动脉疾病患者中,符合高危生理标准者颈动脉内膜切除术后30天卒中/死亡率高达4.7%,不可接受地超过3%阈值。
  • 结果提示需更好地选择患者并在择期颈动脉内膜切除术前进行术前优化。

研究设计与样本

  • 回顾性队列研究,纳入美国外科医师学会国家手术质量改进计划血管靶向数据库2011至2017年所有接受颈动脉内膜切除术的患者。
  • 共识别25788例患者,其中60%因无症状颈动脉疾病接受治疗。
  • 通过预定义变量识别具有高危解剖或生理特征的患者,并与正常风险患者比较。

主要发现

  • 全体患者中,高危生理风险者30天卒中/死亡率为4.6%,正常风险者为2.3%(P < .001)。
  • 全体患者中,高危解剖风险者30天卒中/死亡率为3.6%,正常风险者为2.3%(P < .001)。
  • 高危生理风险者心脏事件率为3.1%,正常风险者为1.6%(P < .001);高危解剖风险者心脏事件率为2.3%,正常风险者为1.6%(P < .01)。
  • 高危解剖风险者颅神经损伤率为4.3%,正常风险者为2.5%(P < .001);高危生理风险者颅神经损伤率为2.4%,正常风险者为2.5%(P = .81)。
  • 无症状患者中,高危生理风险者30天卒中/死亡率为4.7%,正常风险者为1.5%(P < .001);高危解剖风险者为2.6%,正常风险者为1.5%(P < .01)。

关键数值与推荐

  • 当前指南规定颈动脉内膜切除术后可接受的30天卒中/死亡率为无症状患者<3%、症状性患者<6%。
  • 美国医疗保险和医疗补助服务中心已确定某些高危特征,用于定义颈动脉内膜切除术风险最高且可报销颈动脉支架置入的患者。

临床怎么用

  • 对符合高危生理标准的无症状颈动脉疾病患者,择期颈动脉内膜切除术需谨慎评估,30天卒中/死亡风险超过指南阈值。
  • 术前应优化患者生理状态并改进患者选择,以降低高危患者颈动脉内膜切除术后的不良事件风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Current guidelines state that the acceptable 30-day postoperative stroke/death rate after carotid endarterectomy (CEA) is <3% for asymptomatic patients and <6% for symptomatic patients. The Centers for Medicare and Medicaid Services has identified certain high-risk characteristics used to define patients at highest risk for CEA for whom carotid artery stenting would be reimbursed. We evaluated the impact of the Centers for Medicare and Medicaid Services physiologic and anatomic high-risk criteria on major adverse event rates after CEA in asymptomatic and symptomatic patients. METHODS: We retrospectively reviewed all patients undergoing CEA from 2011 to 2017 in the American College of Surgeons National Surgical Quality Improvement Program vascular targeted database. Patients with high-risk anatomic or physiologic characteristics were identified by a predefined variable and were compared with normal-risk patients. The primary outcome was 30-day stroke/death, stratified by symptom status. RESULTS: We identified 25,788 patients undergoing CEA, of whom 60% were treated for asymptomatic carotid disease. Among all patients, high-risk physiology or anatomy was associated with higher rates of 30-day stroke/death compared with normal-risk patients (physiologic risk, 4.6% vs 2.3% [P < .001]; anatomic risk, 3.6% vs 2.3% [P < .001]). Patients who met criteria for high-risk physiology or anatomy also had higher rates of cardiac events (physiologic risk, 3.1% vs 1.6% [P < .001]; anatomic risk, 2.3% vs 1.6% [P < .01]), but only patients with high-risk anatomy had higher rates of cranial nerve injury (physiologic risk, 2.4% vs 2.5% [P = .81]; anatomic risk, 4.3% vs 2.5% [P < .001]). Asymptomatic patients with high-risk physiology or anatomy had higher rates of 30-day stroke/death, especially in the physiologic high-risk group (physiologic risk, 4.7% vs 1.5% [P < .001]; anatomic risk, 2.6% vs 1.5% [P < .01]), compared with normal-risk patients. However, among symptomatic patients, differences in stroke/death were seen only with high-risk anatomic patients and not with high-risk physiologic patients (physiologic risk, 4.6% vs 3.4% [P = .12]; anatomic risk, 4.8% vs 3.4% [P = .01]). CONCLUSIONS: As currently selected, contemporary real-world outcomes after CEA in asymptomatic carotid disease patients meeting high-risk physiologic criteria show an unacceptably high 30-day stroke/death rate, well above the 3% threshold. These results suggest the need for better selection of patients and preoperative optimization before elective CEA.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rao V, Liang P, Swerdlow N, et al. Contemporary outcomes after carotid endarterectomy in high-risk anatomic and physiologic patients. J Vasc Surg. 2019. PMID: 31443978. doi:10.1016/j.jvs.2019.05.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。